IDH3A and central nervous system cancer: 5-Azacytidine, on the other hand, has been studied individually in glioma and GB xenografts16,17, and in patients with recurrent glioma bearing mutations of isocitrate dehydrogenase genes57, as the latter frequently exhibit DNA hypermethylation.